Microbial Sensitivity Tests
"Microbial Sensitivity Tests" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).
| Descriptor ID |
D008826
|
| MeSH Number(s) |
E01.370.225.875.595 E05.200.875.595 E05.337.550.400
|
| Concept/Terms |
Microbial Sensitivity Tests- Microbial Sensitivity Tests
- Microbial Sensitivity Test
- Sensitivity Test, Microbial
- Sensitivity Tests, Microbial
- Test, Microbial Sensitivity
- Tests, Microbial Sensitivity
- Drug Sensitivity Assay, Microbial
Minimum Inhibitory Concentration- Minimum Inhibitory Concentration
- Concentration, Minimum Inhibitory
- Concentrations, Minimum Inhibitory
- Inhibitory Concentration, Minimum
- Inhibitory Concentrations, Minimum
- Minimum Inhibitory Concentrations
Bacterial Sensitivity Tests- Bacterial Sensitivity Tests
- Tests, Bacterial Sensitivity
- Sensitivity Tests, Bacterial
- Test, Bacterial Sensitivity
- Bacterial Sensitivity Test
- Sensitivity Test, Bacterial
|
Below are MeSH descriptors whose meaning is more general than "Microbial Sensitivity Tests".
Below are MeSH descriptors whose meaning is more specific than "Microbial Sensitivity Tests".
This graph shows the total number of publications written about "Microbial Sensitivity Tests" by people in this website by year, and whether "Microbial Sensitivity Tests" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 11 | 13 |
| 1997 | 0 | 7 | 7 |
| 1998 | 0 | 11 | 11 |
| 1999 | 0 | 8 | 8 |
| 2000 | 1 | 15 | 16 |
| 2001 | 1 | 14 | 15 |
| 2002 | 0 | 10 | 10 |
| 2003 | 3 | 22 | 25 |
| 2004 | 0 | 10 | 10 |
| 2005 | 0 | 15 | 15 |
| 2006 | 0 | 16 | 16 |
| 2007 | 0 | 12 | 12 |
| 2008 | 0 | 18 | 18 |
| 2009 | 0 | 12 | 12 |
| 2010 | 0 | 19 | 19 |
| 2011 | 1 | 19 | 20 |
| 2012 | 1 | 14 | 15 |
| 2013 | 1 | 14 | 15 |
| 2014 | 1 | 14 | 15 |
| 2015 | 0 | 18 | 18 |
| 2016 | 0 | 19 | 19 |
| 2017 | 0 | 26 | 26 |
| 2018 | 1 | 16 | 17 |
| 2019 | 4 | 24 | 28 |
| 2020 | 2 | 28 | 30 |
| 2021 | 1 | 22 | 23 |
| 2022 | 1 | 17 | 18 |
| 2023 | 1 | 15 | 16 |
| 2024 | 13 | 7 | 20 |
| 2025 | 0 | 25 | 25 |
| 2026 | 0 | 14 | 14 |
To return to the timeline,
click here.
Below are the most recent publications written about "Microbial Sensitivity Tests" by people in Profiles.
-
Personalized Antibiogram: A Novel Multitask Machine Learning Framework for Simultaneous Prediction of Antimicrobial Resistance Profile With Enhanced Detection of Carbapenem Resistance in Enterobacteriaceae. Clin Infect Dis. 2026 Jul 23; 83(1):e1-e9.
-
Whole-genome profiling of antimicrobial resistance and virulence determinants in extensively-drug resistant Pseudomonas aeruginosa isolates causing ventilator associated pneumonia in Egypt. BMC Infect Dis. 2026 Jul 20; 26(1).
-
Standardized numbering and alignment of the KPC family of ?-lactamases. Antimicrob Agents Chemother. 2026 07; 70(7):e0186825.
-
Rapid phenotypic antimicrobial susceptibility testing of Gram-negative bloodstream isolates: clinical evaluation of the LifeScale AST system. BMC Microbiol. 2026 May 28; 26(1).
-
Total Synthesis of Allocyclinone A via Late-Stage Halogen Swapping. Angew Chem Int Ed Engl. 2026 Jul 01; 65(27):e6162176.
-
Pneumococcal Pneumonia in Hospitalized Children: 2017-2023. Pediatrics. 2026 May 01; 157(5).
-
Genetic Characterization of First-Line Drug-Resistance Mutations in Multidrug-Resistant Mycobacterium tuberculosis. Pathogens. 2026 Apr 22; 15(5).
-
Advancing antimicrobial therapy: evaluating the ASTar (Q-linea) System for rapid AST in Gram-negative bloodstream infections. Microbiol Spectr. 2026 Jun 02; 14(6):e0358125.
-
Reduced catalytic activity of KPC ?-lactamase can increase ceftazidime resistance. Commun Biol. 2026 Apr 07; 9(1).
-
Candesartan cilexetil disrupts methicillin-resistant Staphylococcus aureus membrane and potentiates gentamicin and polymyxin B activity. Nat Commun. 2026 Mar 15; 17(1).